Jun J Yang (Jun Yang)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 35

Top Topics

Acute Myeloid Leukemia

Cognitive Decline

Top Venues

British journal of cancer

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Jun J Yang
Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway. British journal of cancer 130 (4) (2024)
Jun J Yang
Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway. British journal of cancer 130 (4) (2024)
William A Chen, Terry G Williams, Leena So, Natalie Drew, Jie Fang, Pedro Ochoa, Nhi Nguyen, Yasmeen Jawhar, Jide Otiji, Penelope J Duerksen-Hughes, Mark E Reeves, Carlos A Casiano, Hongjian Jin, Sinisa Dovat, Jun J Yang, Kristopher E Boyle, Olivia L Francis-Boyle
Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro. International journal of molecular sciences 25 (8) (2024)
Carolyn M Jablonowski, Waise Quarni, Shivendra Singh, Haiyan Tan, Dhanushka Hewa Bostanthirige, Hongjian Jin, Jie Fang, Ti-Cheng Chang, David Finkelstein, Ji-Hoon Cho, Dongli Hu, Vishwajeeth Pagala, Sadie Miki Sakurada, Shondra M Pruett-Miller, Ruoning Wang, Andrew Jackson Murphy, Kevin Freeman, Junmin Peng, Andrew M Davidoff, Gang Wu, Jun J Yang
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor. eLife 12 (2024)
Jun J Yang
Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway. British journal of cancer 130 (4) (2024)
Xiaofeng Wu, Menchus Quan, Marco Hadisurya, Jianzhong Hu, Yi-Kai Liu, Yuxin Zhuang, Li Li, Anton B Iliuk, Jun J Yang, Shihuan Kuang, Weiguo Andy Tao
Monitoring drug metabolic pathways through extracellular vesicles in mouse plasma. PNAS nexus 3 (2) (2024)
Jun J Yang
Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway. British journal of cancer 130 (4) (2024)
Xiaofeng Wu, Menchus Quan, Marco Hadisurya, Jianzhong Hu, Yi-Kai Liu, Yuxin Zhuang, Li Li, Anton B Iliuk, Jun J Yang, Shihuan Kuang, Weiguo Andy Tao
Monitoring drug metabolic pathways through extracellular vesicles in mouse plasma. PNAS nexus 3 (2) (2024)
William A Chen, Terry G Williams, Leena So, Natalie Drew, Jie Fang, Pedro Ochoa, Nhi Nguyen, Yasmeen Jawhar, Jide Otiji, Penelope J Duerksen-Hughes, Mark E Reeves, Carlos A Casiano, Hongjian Jin, Sinisa Dovat, Jun J Yang, Kristopher E Boyle, Olivia L Francis-Boyle
Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro. International journal of molecular sciences 25 (8) (2024)
William A Chen, Terry G Williams, Leena So, Natalie Drew, Jie Fang, Pedro Ochoa, Nhi Nguyen, Yasmeen Jawhar, Jide Otiji, Penelope J Duerksen-Hughes, Mark E Reeves, Carlos A Casiano, Hongjian Jin, Sinisa Dovat, Jun J Yang, Kristopher E Boyle, Olivia L Francis-Boyle
Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro. International journal of molecular sciences 25 (8) (2024)
William A Chen, Terry G Williams, Leena So, Natalie Drew, Jie Fang, Pedro Ochoa, Nhi Nguyen, Yasmeen Jawhar, Jide Otiji, Penelope J Duerksen-Hughes, Mark E Reeves, Carlos A Casiano, Hongjian Jin, Sinisa Dovat, Jun J Yang, Kristopher E Boyle, Olivia L Francis-Boyle
Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro. International journal of molecular sciences 25 (8) (2024)
Jun J Yang
Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway. British journal of cancer 130 (4) (2024)
Jun J Yang
Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway. British journal of cancer 130 (4) (2024)
Carolyn M Jablonowski, Waise Quarni, Shivendra Singh, Haiyan Tan, Dhanushka Hewa Bostanthirige, Hongjian Jin, Jie Fang, Ti-Cheng Chang, David Finkelstein, Ji-Hoon Cho, Dongli Hu, Vishwajeeth Pagala, Sadie Miki Sakurada, Shondra M Pruett-Miller, Ruoning Wang, Andrew Jackson Murphy, Kevin Freeman, Junmin Peng, Andrew M Davidoff, Gang Wu, Jun J Yang
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor. eLife 12 (2024)
Jun J Yang
Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway. British journal of cancer (2024)
Carolyn M Jablonowski, Waise Quarni, Shivendra Singh, Haiyan Tan, Dhanushka Hewa Bostanthirige, Hongjian Jin, Jie Fang, Ti-Cheng Chang, David Finkelstein, Ji-Hoon Cho, Dongli Hu, Vishwajeeth Pagala, Sadie Miki Sakurada, Shondra M Pruett-Miller, Ruoning Wang, Andrew Jackson Murphy, Kevin Freeman, Junmin Peng, Andrew M Davidoff, Gang Wu, Jun J Yang
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor. eLife 12 (2024)
Jun J Yang
Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway. British journal of cancer (2024)
Jun J Yang
Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway. British journal of cancer (2024)
Carolyn M Jablonowski, Waise Quarni, Shivendra Singh, Haiyan Tan, Dhanushka Hewa Bostanthirige, Hongjian Jin, Jie Fang, Ti-Cheng Chang, David Finkelstein, Ji-Hoon Cho, Dongli Hu, Vishwajeeth Pagala, Sadie Miki Sakurada, Shondra M Pruett-Miller, Ruoning Wang, Andrew Jackson Murphy, Kevin Freeman, Junmin Peng, Andrew M Davidoff, Gang Wu, Jun J Yang
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor. eLife 12 (2024)
Carolyn M Jablonowski, Waise Quarni, Shivendra Singh, Haiyan Tan, Dhanushka Hewa Bostanthirige, Hongjian Jin, Jie Fang, Ti-Cheng Chang, David Finkelstein, Ji-Hoon Cho, Dongli Hu, Vishwajeeth Pagala, Sadie Miki Sakurada, Shondra M Pruett-Miller, Ruoning Wang, Andrew Jackson Murphy, Kevin Freeman, Junmin Peng, Andrew M Davidoff, Gang Wu, Jun J Yang
Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor. eLife 12 (2024)
Xiaofeng Wu, Menchus Quan, Marco Hadisurya, Jianzhong Hu, Yi-Kai Liu, Yuxin Zhuang, Li Li, Anton B Iliuk, Jun J Yang, Shihuan Kuang, Weiguo Andy Tao
Monitoring drug metabolic pathways through extracellular vesicles in mouse plasma. PNAS nexus 3 (2) (2024)
Austin L Brown, Pagna Sok, Kimberly P Raghubar, Philip J Lupo, Melissa A Richard, Alanna C Morrison, Jun J Yang, Clinton F Stewart, M Fatih Okcu, Murali M Chintagumpala, Amar Gajjar, Lisa S Kahalley, Heather Conklin, Michael E Scheurer
Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors. Neuro-oncology (2023)
Manjul Rana, Rita G Kansal, Bijay Bisunke, Jie Fang, David Shibata, Amandeep Bajwa, Jun J Yang, Evan S Glazer
Bromo- and Extra-Terminal Domain Inhibitors Induce Mitochondrial Stress in Pancreatic Ductal Adenocarcinoma. Molecular cancer therapeutics (2023)
Prahalathan Pichavaram, Carolyn M Jablonowski, Jie Fang, Andrew M Fleming, Hyea Jin Gil, Andrew S Boghossian, Matthew G Rees, Melissa A Ronan, Jennifer A Roth, Christopher L Morton, Gerard P Zambetti, Andrew M Davidoff, Jun J Yang, Andrew Jackson Murphy
Oncogenic cells of renal embryonic lineage sensitive to the small molecule inhibitor QC6352 display depletion of KDM4 levels and disruption of ribosome biogenesis. Molecular cancer therapeutics (2023)
Qiong Wu, Brandon M Young, Yan Wang, Andrew M Davidoff, Zoran Rankovic, Jun J Yang
Recent Advances with KDM4 Inhibitors and Potential Applications. Journal of medicinal chemistry 65 (14) (2022)
Xuyong Chen, Benjamin D Sunkel, Meng Wang, Siwen Kang, Tingting Wang, J N Rashida Gnanaprakasam, Lingling Liu, Teresa A Cassel, David A Scott, Ana M Muñoz-Cabello, José López-Barneo, Jun J Yang, Andrew N Lane, Gang Xin, Benjamin Z Stanton, Teresa W-M Fan, Ruoning Wang
Succinate dehydrogenase/complex II is critical for metabolic and epigenetic regulation of T cell proliferation and inflammation. Science immunology 7 (70) (2022)
Jun J Yang, Andrew M Davidoff
Remarkable Synergy When Combining EZH2 Inhibitors with YM155 Is H3K27me3-Independent. Cancers 15 (1) (2022)
Jun J Yang, Andrew M Davidoff
Remarkable Synergy When Combining EZH2 Inhibitors with YM155 Is H3K27me3-Independent. Cancers 15 (1) (2022)
Carolyn M Jablonowski, Hyea Jin Gil, Emilia Modolo Pinto, Prahalathan Pichavaram, Andrew M Fleming, Michael R Clay, Dongli Hu, Christopher L Morton, Shondra M Pruett-Miller, Baranda S Hansen, Xiang Chen, Karissa M Dieseldorff Jones, Yanling Liu, Xiaotu Ma, Jun J Yang, Andrew M Davidoff, Gerard P Zambetti, Andrew Jackson Murphy
TERT Expression in Wilms Tumor Is Regulated by Promoter Mutation or Hypermethylation, WT1, and N-MYC. Cancers 14 (7) (2022)
Jun J Yang, Andrew M Davidoff
Remarkable Synergy When Combining EZH2 Inhibitors with YM155 Is H3K27me3-Independent. Cancers 15 (1) (2022)
Jun J Yang, Andrew M Davidoff
Remarkable Synergy When Combining EZH2 Inhibitors with YM155 Is H3K27me3-Independent. Cancers 15 (1) (2022)
Shivendra Singh, Ahmed Abu-Zaid, Hongjian Jin, Jie Fang, Qiong Wu, Tingting Wang, Helin Feng, Waise Quarni, Ying Shao, Lily Maxham, Alireza Abdolvahabi, Mi-Kyung Yun, Sivaraja Vaithiyalingam, Haiyan Tan, John Bowling, Victoria Honnell, Brandon M Young, Yian Guo, Richa Bajpai, Shondra M Pruett-Miller, Gerard C Grosveld, Mark E Hatley, Bei-Si Xu, Yiping Fan, Gang Wu, Eleanor Y Chen, Taosheng Chen, Peter W Lewis, Zoran Rankovic, Yimei Li, Andrew Jackson Murphy, John Easton, Junmin Peng, Xiang Chen, Ruoning Wang, Stephen W White, Andrew M Davidoff, Jun J Yang
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma. Science translational medicine 14 (653) (2022)
Jun J Yang, Andrew M Davidoff
Remarkable Synergy When Combining EZH2 Inhibitors with YM155 Is H3K27me3-Independent. Cancers 15 (1) (2022)
Shivendra Singh, Waise Quarni, Maria Goralski, Shibiao Wan, Hongjian Jin, Lee-Ann Van de Velde, Jie Fang, Qiong Wu, Ahmed Abu-Zaid, Tingting Wang, Ravi Singh, David Craft, Yiping Fan, Thomas Confer, Melissa Johnson, Walter J Akers, Ruoning Wang, Peter J Murray, Paul Glyndwr Thomas, Deepak Nijhawan, Andrew M Davidoff, Jun J Yang
Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models. Science advances 7 (47) (2021)
Jun J Yang, Adrian L Harris, Andrew M Davidoff
Hypoxia and Hormone-Mediated Pathways Converge at the Histone Demethylase KDM4B in Cancer. International journal of molecular sciences 19 (1) (2018)